Clorox Company (The) (CLX) Revenue-to-Profit Sankey Flow & SEC XBRL Financials
Clorox Company (The) (CLX) receives a Roarable Rating of D+ (Sell) and flashes a Red SELL / AVOID warning (65/100 RQD Confidence). Our SEC filing scanner spotted paper earnings outpacing real operating cash flow (+141.0% (NI vs OCF)) while unpaid customer invoices grew—a classic sign to step aside until cash flow catches up.
How CLX Turns Every Dollar of Sales Into Real Bottom-Line Profit
Multi-Year SEC EDGAR XBRL Revenue, Net Profit & Free Cash Flow Trajectory
| Fiscal Year | Revenue | Gross Margin | Op Margin | Net Profit | Free Cash Flow | ROIC % |
|---|---|---|---|---|---|---|
| FY 2025 | $7.10B | 45.2% | 13.7% | $824.0M | $761.0M | 36% |
| FY 2024 | $7.09B | 43% | 4.9% | $292.0M | $483.0M | 12.6% |
| FY 2023 | $7.39B | 44% | 2.6% | $161.0M | $825.5M | 2.8% |
Red-Light Warning Desk: How Pros Profit When Overhyped Stocks Crack (Featuring CLX)
- ✓Live walkthrough of CLX's RQD Radar, SEC cash-conversion gap & downside levels
- ✓3 asymmetric Bear/Hedge setups institutions use when 10-year yields stay elevated
- ✓Includes instant 24/7 email alert whenever any of your stocks flip to Red
CLX Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +0.2% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on CLX today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for CLX. Explore sector supply chains on /butterfly.
CLX Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDHow profitable is Clorox Company (The) (CLX)?
In FY 2025 (10-K), CLX converted $7.1B of revenue into a 45.2% gross margin, 13.7% operating margin, and $761.0M in free cash flow (10.7% FCF margin).